Jeffrey Sum Lung Wong

Author

Also Known As

J. Wong, Jeffrey S L Wong, Jeffrey Sum Lung Wong, Jeffrey Sum-Lung Wong

Publications

440

Citations

H-Index

Concepts

All Affiliations

Jeffrey Sum Lung Wong is an author at University of Hong Kong specializing in medicine, pathology, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	109
2	Pathology	3	3	86
3	Hepatology	2	2	61
4	Health Sciences	1	1	51
5	Immunology	1	1	23

Jeffrey Sum Lung Wong

Publications

315

Citations

H-Index

Page 1

	Year	Citations
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang, Journal for ImmunoTherapy of Cancer	2021	126
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma Hiroto Kikuchi, Aya Matsui, Satoru Morita, JNCI Journal of the National Cancer Institute	2022	67
Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma Jarley Koo, Kin Fen Kevin Fung, K.F. Siu, Cancer Right AtriumSurgical OncologyPathologyTumor CellsSurgery	1983	51
Telomerase activity in small cell esophageal carcinoma Vivian Chow, Simon Law, Alfred K. Lam, Diseases of the Esophagus Esophageal CancerMalignant DiseaseOncogenic AgentMedicineTelomerase Activity	2001	25
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors. Jeffrey Sum Lung Wong, Gin Wai Kwok, Vikki Tang, Journal of Clinical Oncology ImmunologyImmunoeditingAdvanced Hcc PatientsImmunotherapeuticsImmunotherapy	2021	23
The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort Study Jeffrey Sum Lung Wong, Yawen Dong, Vikki Tang, Cancers	2021	13
Hepatocellular carcinoma in Asia Jeffrey Sum Lung Wong The HKU Scholars Hub (University of Hong Kong) HepatologyHistopathologyPathologyLiver CancerLiver	1996	10

Page 1